Skip to content

Protective effect and metabolic analysis of propofol on myocardial injury in sepsis

Protective effect and metabolic analysis of propofol on myocardial injury in sepsis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055772
Enrollment
Unknown
Registered
2022-01-19
Start date
2022-01-14
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Sepsis experimental group:Propofol group was given a sedative load of 2.5mg/kg propofol for 10min, followed by continuous pumping at 1mg/kg/h for 6h
Sepsis control group:sedated with Midazolam 0.05mg/kg, infusion time was 10min, and 0.9% normal saline was continuously pumped in the same way at the same volume and speed

Sponsors

PLA Army Specialty Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as sepsis (1) Since the previous diagnostic indexes of "infection +SIRS presentation" are considered too sensitive, the current clinical diagnosis of adult sepsis requires definite infection or suspected infection plus the following indexes: 1) general condition: fever (>38.3?) or hypothermia (90 beats/min) or > 2 sd above normal for age; Increased respiration (>30 times/min); Consciousness change; Obvious edema or positive fluid balance > 20 ml/kg, lasting for more than 24h; Hyperglycemia (blood glucose >7.7mmol/L) and no history of diabetes; 2) Inflammatory indicators: leukopenia (>12 x 10^9/L or leukopenia (10%; Plasma C-reactive protein > normal value by 2 standard deviations; Plasma procalcitonin > normal by 2 standard deviations; 3) Hemodynamic indicators: hypotension (systolic blood pressure mmHg, mean arterial blood pressure 40 mmHg, or 2 standard deviations below normal for age); Mixed venous oxygen saturation (SvO2) > 70%; Cardiac index (CI) > 3.5 L/min/m2; 4) Organ dysfunction parameters: oxygenation index (PaO2/FiO2) Acute oliguria (urine volume 1.5 or activated partial thrombin time > 60s); Intestinal paralysis: the disappearance of intestinal sounds; Thrombocytopenia (70mmol/L); 5) Tissue perfusion parameters: hyperlactacemia (> 3 mmol/L); Prolonged capillary refill time or skin emergence; (2) Severe sepsis: sepsis complicated with organ dysfunction; (3) Septic shock: an otherwise unexplained state of acute circulatory failure characterized by hypotension, which is a specific type of severe sepsis. Include: 1) Systolic blood pressure 40mmHg for at least 1 hour, or dependent on infusion and medication to maintain blood pressure, mean arterial pressure 2 s; 3) Cold limbs or skin spots; 4) Hyperlactacemia; 5) Decreased urine output; 2. The patient gave informed consent, participated voluntarily, and signed the informed consent form; 3. Age: 18-80 years, 80 inclusive; 4. Register general medical conditions.

Exclusion criteria

Exclusion criteria: 1. Previous history of chronic heart disease, liver and kidney diseases; 2. Pregnant or menstruating women; 3. Preoperative radiotherapy and chemotherapy, and previous thoracic organ surgery (heart, lung, mediastinum); 4. Complicated with cardiovascular, liver, kidney and hematopoietic system and other serious primary diseases, as well as serious diseases affecting their quality of life; 5, Diabetes, hba1c > 7%; 6. Hyperthyroidism and abnormal thyroid function; 7. Abnormal blood lipid and uric acid metabolism; 8. Patients with mental diseases, cerebrovascular diseases or craniocerebral trauma; 9, Long-term use of sedative drugs or alcohol patients.

Design outcomes

Primary

MeasureTime frame
Metabolomics test results;

Secondary

MeasureTime frame
arterial blood gas analysis;Oxidative stress index;markers of myocardial injury;

Countries

China

Contacts

Public ContactLi Tao

PLA Army Specialty Medical Center

541350208@qq.com+86 13101229698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026